Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III

Alimentary Pharmacology and Therapeutics

Volumn 26, Issue 6, 2007, Pages 953-961

  Ersryd, A ^a   Posserud, I ^a   Abrahamsson, H ^a   Simren M ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONSTIPATION; CONTROLLED STUDY; DEFECATION HABIT; DEMOGRAPHY; DIARRHEA; DISEASE CLASSIFICATION; FEMALE; HUMAN; IRRITABLE COLON; KAPPA STATISTICS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE;

ADOLESCENT; ADULT; AGED; CONSTIPATION; DIARRHEA; FEMALE; GASTROINTESTINAL TRANSIT; HEALTH STATUS; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RETROSPECTIVE STUDIES;

EID: 34548305009     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2007.03422.x     Document Type: Article

References (37)

1. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006 130 : 1480 91.
2. Agréus L, Svärdsudd K, Nyrén O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995 109 : 671 80.
3. Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993 38 : 1569 80.
4. Bouin M, Plourde V, Boivin M, et al. Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology 2002 122 : 1771 7.
5. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995 109 : 40 52.
6. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999 45 (Suppl. 2 II43 7.
7. Mearin F, Baro E, Roset M, Badia X, Zarate N, Perez I. Clinical patterns over time in irritable bowel syndrome: symptom instability and severity variability. Am J Gastroenterol 2004 99 : 113 21.
8. Camilleri M, Chey WY, Mayer EA, et al. A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome. Arch Intern Med 2001 161 : 1733 40.
9. Chey WD. Review article: tegaserod - the global experience. Aliment Pharmacol Ther 2004 20 (Suppl. 7 15 9.
10. Muller-Lissner SA, Fumagalli I, Bardhan KD, et al. Tegaserod, a 5-HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment Pharmacol Ther 2001 15 : 1655 66.
11. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. In : Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, eds. The Functional Gastrointestinal Disorders, 2nd edn. Washington : Degnon, 2000 : 351 432.
12. Rome II Modular Questionnaire: investigator and respondent forms. In : Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, eds. Rome II The Functional Gastrointestinal Disorders, 2nd edn. McLean, VA, USA : Degnon Associates, 2000 : 669 88.
13. Drossman DA, Morris CB, Hu Y, et al. A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator. Gastroenterology 2005 128 : 580 9.
14. Tillisch K, Labus JS, Naliboff BD, et al. Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome. Am J Gastroenterol 2005 100 : 896 904.
15. Heaton KW, Ghosh S, Braddon FE. How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form. Gut 1991 32 : 73 9.
16. Mearin F, Balboa A, Badia X, et al. Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype. Eur J Gastroenterol Hepatol 2003 15 : 165 72.
17. Ragnarsson G, Bodemar G. Pain is temporally related to eating but not to defaecation in the irritable bowel syndrome (IBS). Patients' description of diarrhea, constipation and symptom variation during a prospective 6-week study. Eur J Gastroenterol Hepatol 1998 10 : 415 21.
18. Ragnarsson G, Bodemar G. Division of the irritable bowel syndrome into subgroups on the basis of daily recorded symptoms in two outpatients samples. Scand J Gastroenterol 1999 34 : 993 1000.
19. O'Donnell LJ, Virjee J, Heaton KW. Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate. BMJ 1990 300 : 439 40.
20. Altman DG. Practical statistics for medical research: Chapman & Hall/CRC 1991.
21. Manning AP, Wyman JB, Heaton KW. How trustworthy are bowel histories? Comparison of recalled and recorded information. BMJ 1976 2 : 213 4.
22. Walter SA, Ragnarsson G, Bodemar G. New criteria for irritable bowel syndrome based on prospective symptom evaluation. Am J Gastroenterol 2005 100 : 2598 9.
23. Walter SA, Skagerstrom E, Bodemar G. Subgroups of irritable bowel syndrome: a new approach. Eur J Gastroenterol Hepatol 2004 16 : 991 4.
24. Gomborone JE, Dewsnap PA, Libby GW, Farthing MJ. Selective affective biasing in recognition memory in the irritable bowel syndrome. Gut 1993 34 : 1230 3.
25. Garrigues V, Mearin F, Badia X, et al. Change over time of bowel habit in irritable bowel syndrome: a prospective, observational, 1-year follow-up study (RITMO study). Aliment Pharmacol Ther 2007 25 : 323 32.
26. Guilera M, Balboa A, Mearin F. Bowel habit subtypes and temporal patterns in irritable bowel syndrome: systematic review. Am J Gastroenterol 2005 100 : 1174 84.
27. Wyman JB, Heaton KW, Manning AP, Wicks AC. Variability of colonic function in healthy subjects. Gut 1978 19 : 146 50.
28. Naliboff BD, Munakata J, Fullerton S, et al. Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut 1997 41 : 505 12.
29. Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects. Aliment Pharmacol Ther 2003 17 : 643 50.
30. Simrén M, Abrahamsson H, Svedlund J, Björnsson ES. Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: the impact of gender and predominant bowel pattern. Scand J Gastroenterol 2001 36 : 545 52.
31. Thompson WG, Heaton KW, Smyth GT, Smyth C. Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut 2000 46 : 78 82.
32. Owens DM, Nelson DK, Talley NJ. The irritable bowel syndrome: long-term prognosis and the physician- patient interaction. Ann Intern Med 1995 122 : 107 12.
33. Schmulson M, Lee OY, Chang L, Naliboff B, Mayer EA. Symptom differences in moderate to severe IBS patients based on predominant bowel habit. Am J Gastroenterol 1999 94 : 2929 35.
34. Lee OY, Mayer EA, Schmulson M, Chang L, Naliboff B. Gender-related differences in IBS symptoms. Am J Gastroenterol 2001 96 : 2184 93.
35. Shiotani A, Miyanishi T, Takahashi T. Sex differences in irritable bowel syndrome in Japanese university students. J Gastroenterol 2006 41 : 562 8.
36. Talley NJ, Dennis EH, Schettler-Duncan VA, Lacy BE, Olden KW, Crowell MD. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol 2003 98 : 2454 9.
37. Pasricha PJ. Desperately seeking serotonin. A commentary on the withdrawal of tegaserod and the state of drug development for functional and motility disorders. Gastroenterology 2007 132 : 2287 90.